DeRubeis-Hollon
2005
Cognitive Therapy vs Medications in Moderate-to-Severe Depression
In 240 outpatients with moderate-to-severe MDD, 16 weeks of cognitive therapy matched response and protected against relapse after taper compared with paroxetine or pill placebo.
Result
Primary endpoint: HRSD response at 16 wk and 12-month relapse
Acute response 58% (CT) vs 58% (paroxetine) vs 25% (placebo). After withdrawal, relapse 31% (CT) vs 76% (medication taper).
- Subtopic
- CBT vs pharma
- Design
- RCT + 12-month continuation, USA
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Cited in
- NICE NG222 Depression
- Source
- DeRubeis RJ, et al. Arch Gen Psychiatry. 2005;62(4):409-416.doi 10.1001/archpsyc.62.4.409
Discussion & critique
First trial to show CT can match antidepressants in severe MDD and to deliver a durable post-treatment effect.